Sensodyne is owned by Haleon (the United Kingdom, LSE: HLN), which was separated from GSK on 18 July 2022.[1][2] Before Haleon, Sensodyne was owned by GSK from 2000 to 2022.[2]
Sensodyne is a toothpaste for sensitive teeth, launched in 1961 using strontium chloride to block the dentine tubules that transmit pain. It is the largest sensitivity toothpaste in the world and Haleon's single biggest brand.
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Haleon ownership tree →
GSK demerged its consumer healthcare business as Haleon, listing it in London and New York in July 2022. The business already contained Pfizer's consumer health portfolio, contributed to a joint venture in 2019, which is how Advil and Centrum came to sit alongside Sensodyne and Panadol.
No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
1 recall notice from government regulators matched to Sensodyne. Each applies to the specific products, sizes and lot codes named in the notice, not to every product sold under the name.
Reason given: Labeling: Label Mix-up: The outer carton is labelled Fresh Mint. The tube is labelled Cool Mint/Whitening. The toothpaste inside the tube is Fresh Mint as indicated on the outer…
Recalling firm: Haleon US Holdings LLC
Matched automatically from FDA, USDA FSIS, UK Food Standards Agency and CPSC records only when the recalling firm corresponds to this ownership record and, for a brand, the brand name appears in the product description. Check the linked notice for exact products and lots. Method.
The parent company of Sensodyne is Haleon, a publicly listed company headquartered in the United Kingdom.
Sensodyne originated in the United States in 1961, but it is owned today by Haleon, which is headquartered in the United Kingdom. So Sensodyne is an American-origin brand under British ownership.
Haleon has owned Sensodyne since 18 July 2022.
Before Haleon, Sensodyne was owned by GSK from 2000 until 2022.
Yes. As of 16 September 2026, Sensodyne is still owned by Haleon. The ownership record was last checked against primary sources on that date.
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.